Gray Foundation Ascendis Pharma A/S Transaction History
Gray Foundation
- $337 Billion
- Q3 2024
A detailed history of Gray Foundation transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Gray Foundation holds 51,700 shares of ASND stock, worth $6.34 Million. This represents 2.29% of its overall portfolio holdings.
Number of Shares
51,700
Previous 51,700
-0.0%
Holding current value
$6.34 Million
Previous $7.05 Billion
9.48%
% of portfolio
2.29%
Previous 2.16%
Shares
1 transactions
Others Institutions Holding ASND
# of Institutions
243Shares Held
58.8MCall Options Held
250KPut Options Held
377K-
Ra Capital Management, L.P. Boston, MA9.71MShares$1.19 Billion20.22% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.13MShares$630 Million3.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.99MShares$612 Million11.21% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.41MShares$541 Million1.03% of portfolio
-
Janus Henderson Group PLC London, X04.19MShares$513 Million0.33% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $6.84B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...